IS6559A - Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum - Google Patents

Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum

Info

Publication number
IS6559A
IS6559A IS6559A IS6559A IS6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A IS 6559 A IS6559 A IS 6559A
Authority
IS
Iceland
Prior art keywords
mammals
treat
prevent bacterial
azalide antibiotic
antibiotic formulations
Prior art date
Application number
IS6559A
Other languages
English (en)
Inventor
Alan Boettner Wayne
Connor Canning Peter
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS6559A publication Critical patent/IS6559A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IS6559A 2000-04-27 2002-09-20 Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum IS6559A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27
PCT/IB2001/000519 WO2001081358A1 (en) 2000-04-27 2001-03-26 The use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals

Publications (1)

Publication Number Publication Date
IS6559A true IS6559A (is) 2002-09-20

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6559A IS6559A (is) 2000-04-27 2002-09-20 Notkun á azalíð sýklalyfssamsetningum til að meðhöndla eða fyrirbyggja bakteríu- eða frumdýrasýkingu í spendýrum

Country Status (30)

Country Link
US (2) US20020019353A1 (is)
EP (1) EP1276747A1 (is)
JP (1) JP2004516233A (is)
KR (1) KR20030031479A (is)
CN (1) CN1227258C (is)
AP (1) AP2002002652A0 (is)
AR (1) AR028041A1 (is)
AU (1) AU4269301A (is)
BG (1) BG107168A (is)
BR (1) BR0110382A (is)
CA (1) CA2407448A1 (is)
CZ (1) CZ20023409A3 (is)
EA (1) EA200200995A1 (is)
GT (1) GT200100063A (is)
HU (1) HUP0300585A3 (is)
IL (1) IL152421A0 (is)
IS (1) IS6559A (is)
MA (1) MA26896A1 (is)
MX (1) MXPA02010586A (is)
NO (1) NO20025134L (is)
OA (1) OA12257A (is)
PA (1) PA8515601A1 (is)
PE (1) PE20011188A1 (is)
PL (1) PL359861A1 (is)
SK (1) SK14882002A3 (is)
TN (1) TNSN01063A1 (is)
UY (1) UY26678A1 (is)
WO (1) WO2001081358A1 (is)
YU (1) YU78702A (is)
ZA (1) ZA200208603B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
WO2003011266A2 (en) * 2001-08-01 2003-02-13 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
PL2680833T3 (pl) * 2011-03-04 2016-08-31 Gruenenthal Gmbh Pozajelitowe podawanie tapentadolu
KR102104921B1 (ko) * 2012-06-27 2020-04-28 케민 인더스트리즈, 인코포레이티드 항콕시듐 활성을 갖는 식물 부분 및 추출물
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
MX2018015344A (es) 2016-12-15 2019-04-29 Nestec Sa Composiciones y metodos que modulan las bacterias en un animal de compañía.
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
AU2018225390B2 (en) * 2017-02-22 2021-07-22 ISR Immune System Regulation Holding AB (publ) Novel immune stimulating macrolides
AU2019385333B2 (en) * 2018-11-19 2025-04-17 President And Fellows Of Harvard College C10-alkylene substituted 13-membered macrolides and uses thereof
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
US12390440B2 (en) 2020-03-12 2025-08-19 Zoetis Services Llc Immunomodulating trifluoromethyl-aminal azalides
AU2022343476B2 (en) * 2021-09-07 2025-02-20 Zoetis Services Llc Immunomodulating azalides
CN121360074A (zh) * 2025-05-07 2026-01-20 普莱柯生物工程股份有限公司 莱柯霉素注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
MA26896A1 (fr) 2004-12-20
UY26678A1 (es) 2001-12-28
PL359861A1 (en) 2004-09-06
PA8515601A1 (es) 2002-07-30
PE20011188A1 (es) 2001-11-24
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
KR20030031479A (ko) 2003-04-21
OA12257A (en) 2003-11-06
US20020019353A1 (en) 2002-02-14
NO20025134D0 (no) 2002-10-25
YU78702A (sh) 2005-11-28
TNSN01063A1 (fr) 2005-11-10
AU4269301A (en) 2001-11-07
BR0110382A (pt) 2003-06-24
CZ20023409A3 (cs) 2004-01-14
HUP0300585A3 (en) 2003-09-29
EP1276747A1 (en) 2003-01-22
CN1429232A (zh) 2003-07-09
CN1227258C (zh) 2005-11-16
EA200200995A1 (ru) 2003-04-24
SK14882002A3 (en) 2004-11-03
CA2407448A1 (en) 2001-11-01
NO20025134L (no) 2002-12-19
MXPA02010586A (es) 2003-03-10
JP2004516233A (ja) 2004-06-03
BG107168A (bg) 2003-07-31
HUP0300585A2 (hu) 2003-06-28
WO2001081358A1 (en) 2001-11-01
ZA200208603B (en) 2003-10-24
AR028041A1 (es) 2003-04-23
AP2002002652A0 (en) 2002-12-31
US20040235759A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
ITRM980103A0 (it) Uso di batteri dotati di arginina deiminasi per introdurre apostosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
ATE277063T1 (de) 6-o-alkylerythromycinoxim b
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
AP2003002906A0 (en) Crystal forms of azithromycin
IS6177A (is) Samsetning af mjólkursýrugerlum og notkun hennar til að fyrirbyggja og/eða meðhöndla sýkingar og bólguástand
NO20021721D0 (no) C-aryl-glukosid-SGLT2-inhibitorer
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
IL148641A0 (en) Topical treatment of streptococcal infections
ATE243703T1 (de) Antibiotische azalid-zusammensetzungen
EP1171428A4 (en) FAB-I INHIBITORS
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
AU6174900A (en) Use of flavones, coumarins and related compounds to treat infections
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
ATE345350T1 (de) Makrolidantibiotika
BR9909994A (pt) Quinolinas usadas como inibidores de mrs e bactericidas
FR11C0037I2 (fr) Antibiotiques macrolides et traitement de la pasteurellose
BR0010220A (pt) Compostos de pirimidinona
NO20025134L (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjon hos pattedyr
DK1131331T3 (da) 13-leddede azalider og deres anvendelse som antibiotiske midler
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
EP1328278A4 (en) ANALGETIC AND GLUCOSAMINE COMPOSITIONS
AU2002364964A8 (en) Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections
PT1168920E (pt) Composicao de fipronil enriquecida em enantiomero (s)
PT1165031E (pt) Composicao do resorcinol